Jiangxi Fushine Pharmaceutical (300497.SZ) obtained GMP certification from the Brazilian National Health Surveillance Agency.

16:43 26/11/2025

Fusheng Pharmaceutical (300497.SZ) announced that the company has obtained approval from the Brazilian National Health Surveillance Agency (ANVISA)...

Jiangxi Fushine Pharmaceutical (300497.SZ) announced that the company has obtained the Good Manufacturing Practice (GMP) certification certificate for drug production quality management issued by the National Health Surveillance Agency (ANVISA) of Brazil. The certification scope is for the active pharmaceutical ingredient: terbinafine.

Aftermath of First Brands bankruptcy: UBS Group AG (UBS.US) credit fund faces a 10% write-down.

WING ON CO (00289) spent 52,300 Hong Kong dollars to buy back 4,000 shares on November 26th.

Wanbangde Pharmaceutical Holding Group (002082.SZ): Obtained drug registration certificate for sildenafil oral suspension

Aftermath of First Brands bankruptcy: UBS Group AG (UBS.US) credit fund faces a 10% write-down.

WING ON CO (00289) spent 52,300 Hong Kong dollars to buy back 4,000 shares on November 26th.

Wanbangde Pharmaceutical Holding Group (002082.SZ): Obtained drug registration certificate for sildenafil oral suspension